STOCKHOLM (Reuters) – Hygiene products group Essity reported on Friday a slightly bigger drop than expected in first-quarter operating profit and said it expected COVID-19 vaccine programmes to boost demand for many of its product categories.
Operating earnings fell 32% from a year earlier to 3.48 billion crowns ($413.3 million). Analysts had on average predicted a profit of 3.64 billion crowns, according to Refinitiv data.
(Reporting by Anna Ringstrom, editing by Helena Soderpalm)
